About this trial
Migraine is a highly prevalent neurological disorder associated with recurrent headache, disability, and reduced quality of life. In addition to pain, migraine is frequently accompanied by autonomic dysfunction, psychological comorbidities, and sleep disturbances. Manual lymphatic drainage (MLD) is a physiotherapy technique that may influence pain perception and autonomic regulation by promoting lymphatic and venous return and facilitating parasympathetic activity.
The aim of this pilot clinical study is to evaluate the effectiveness of manual lymphatic drainage in patients with migraine. Participants will be allocated to an experimental group receiving manual lymphatic drainage or to a control group. Outcomes related to pain intensity, pressure pain thresholds, migraine-related disability, quality of life, psychological variables, sleep quality, and vital signs will be assessed at baseline, after the intervention, and during follow-up periods.
This study seeks to provide preliminary evidence on the feasibility and potential clinical effects of manual lymphatic drainage as a non-pharmacological physiotherapy approach for migraine management.
Eligibility criteria
Qualifiers
Male or female, aged 20 to 55 years.
Clinical diagnosis of migraine and experiencing migraine episodes with a minimum frequency of 4 times per month.
Disqualifiers
Participants with arterial hypertension who are taking antihypertensive medication.
Participants currently taking prophylactic medication for migraine.
Participants with fibromyalgia.
Trial design
Treatments tested in this trial
- Manual lymphatic drainage